Amna Aslam

Amna M. Aslam, MBA, MSc, is the Applied Research Specialist at Radial Health and serves as Expert Faculty for the American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3). She provides strategic research expertise in clinical outcomes research, post-marketing evidence generation, and health economics, with a focus on translating real-world data into evidence that informs clinical standard practices, healthcare decision-making, and patient access to innovative neuropsychiatric therapies.

‍
Amna’s work spans the design and oversight of real-world evidence and post-marketing studies, clinical outcomes and patient-reported outcomes, and health economics and outcomes research (HEOR) across interventional psychiatry and neurology. She has led numerous investigator-initiated studies, retrospective analyses, prospective observational studies, and scientific publications evaluating innovative neuropsychiatric therapies. Her expertise includes comparative effectiveness research and health economic evaluations, including cost-effectiveness (CEA), cost-utility (CUA), cost-benefit (CBA), budget impact, and quality-adjusted life year (QALY) analyses. She leverages advanced statistical methodologies using SAS, SPSS, and R to generate robust clinical, economic, and patient-centered evidence that informs value-based healthcare decision-making.

‍
Amna earned her Master of Business Administration and Master of Science in Pharmacy Administration with a concentration in Health Economics and Outcomes Research from St. John's University. She previously contributed to research and market access initiatives at Fermata Health and has served as an Community Affairs and Constituent Laison at her local NYS AssemblyMembers Office. Moreover she has served as adjunct professor and graduate research and teaching assistant at St. John's University. Outside of work, Amna enjoys traveling, trying new restaurants, and learning about the intersection of government and healthcare.